For Rules on Creating ‘CRISPR babies’ from Edited Embryos, Scientists Call a Do-over
By Sharon Begley,
STAT
| 08. 12. 2019
The second-most shocking thing He Jiankui told the international genome editing summit in Hong Kong last November was that he’d followed guidelines.
The second-most shocking thing He Jiankui told the international genome editing summit in Hong Kong last November — right after announcing that twin girls had been born from embryos whose DNA he’d changed with CRISPR — was that he’d followed guidelines on embryo editing set forth by a panel of leading U.S. scientists and ethicists.
That committee of the National Academies of Science, Engineering, and Medicine basically said, in 2017: If society agrees this is OK, proceed with extreme caution. He claimed he had checked all the panel’s boxes, meeting a long list of criteria that include editing only genes “convincingly demonstrated” to cause the disease, conducting “credible” animal studies first, and having “reliable oversight mechanisms.”
Whether he honestly believes that, or is just claiming to as a way of spreading around the blame for a dangerous, unethical experiment, is anyone’s guess. But his statement horrified virtually everyone — and no one more than members of that 2017 committee.
“It was a shock,” said biologist Richard Hynes of the Massachusetts Institute of Technology, the committee co-chair. Regardless of what He...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...